Episode Summary
Executive Summary: The episode argues that quantum technologies are commercially viable today when paired with AI. Jack Hidary explains Sandbox AQ’s products across navigation, medicine, drug discovery, and cybersecurity: quantum sensors plus AI can replace brittle GPS, detect cardiac signals in under five minutes, accelerate molecular modeling, and help organizations migrate to post-quantum cryptography before future quantum attacks arrive.
Main Topics: Quantum technologies as a current business: Hidary frames Sandbox AQ as proof that quantum-related technologies can generate real revenue now by combining quantum methods with quantitative AI for enterprise customers. Quantum navigation (AQ-NAV) as GPS alternative: He explains how magnetic-field sensing and AI can navigate in GPS-denied or spoofed environments, especially for defense, aviation, underwater, and underground use. Quantum sensing for cardiac diagnostics: The discussion shifts to magnetocardiography, where quantum sensors and AI detect the heart’s magnetic field to triage chest pain faster than traditional troponin testing. Drug discovery with large quantitative models: Hidary describes using physics-based models and AI to simulate molecular interactions, reduce discovery time/cost, and improve candidate selection before clinical trials. Post-quantum cybersecurity and ActiveGuard: The final major topic covers the threat quantum computers pose to RSA/ECC encryption and Sandbox AQ’s tool for inventorying and migrating organizational cryptography. Limits of current quantum computing and near-term value of sensing: He distinguishes today’s practical quantum sensing and AI applications from fault-tolerant quantum computers, which he says are still years away.
Key Arguments: Quantum is already a business when combined with AI; Sandbox AQ claims real customers and revenue today rather than distant future potential. GPS is fragile because it can be jammed, spoofed, or disabled in places where satellite signals fail, making alternative navigation systems urgent. Earth’s magnetic crustal map can serve as a navigational fingerprint when read by quantum sensors and interpreted by AI. The hardest problem in sensor applications is not sensing itself but filtering extreme environmental noise with quantitative AI. Magnetocardiography can detect the heart’s magnetic signals noninvasively and more quickly than standard ER-based blood testing. Current chest-pain triage is slow and imprecise; a five-minute scan could improve emergency-room throughput and patient outcomes. Quantum-based molecular modeling can generate the data needed to simulate drug binding and off-target effects, improving drug discovery efficiency. The pharmaceutical pipeline is structurally inefficient because most candidates fail and many approved drugs are only incremental improvements. Quantum computers will eventually break RSA and ECC, so institutions must inventory and migrate cryptography now. ActiveGuard’s main value is diagnostics: continuous scanning of systems to identify encryption in use and prioritize migration to post-quantum standards.
Data Points: Sandbox AQ funding: $500 million - Raised around two and a half years after spinning out of Alphabet. Company age at interview: About 2.5 years - Time since Sandbox AQ spun out. Number of serious quantum-computing outfits: About three dozen - Hidary estimates the number of significant quantum computer builders. GPS availability in the world: 4 major systems - U.S., Europe, Russia, and China each have their own satellite navigation systems. Arctic tern migration distance: 24,000 kilometers per year - Used as an example of animal magnetoreception. Cardiac disease ranking: #1 killer in the United States - Stated for both men and women. Heart-attack presentations in U.S. ERs: 8 million per year - Chest-pain cases requiring rapid triage. Heart attack symptom prevalence: 70% have no precedent symptoms - Used to emphasize the need for better diagnostics. Troponin testing time: 2+ hours for one draw; 4-6 hours often with two draws - Compared with Sandbox AQ’s under-five-minute device. Drug development timeline: 8-10 years preclinical - Average time before a molecule reaches phase one trials. Clinical trial failure rate: 90% - Used to describe the current pharmaceutical development process. New drug approvals per year: 48-50 - Average annual approvals worldwide. First-in-human novel drugs: About a dozen per year - Most approvals are said to be me-too drugs. Cryptography migration timeline: 7-10 years - Typical enterprise migration from RSA/ECC to new protocols. Post-quantum standardization date: August 13, 2024 - Governments announced standardized post-quantum cryptography protocols.
Pivotal Quotes: "GPS is very brittle." — Jack Hidary: Opening argument for why alternative navigation technologies are needed. "The hardest part actually wasn’t the quantum side, it was the AI side." — Jack Hidary: Explaining why filtering signal from noise is central to both navigation and medical sensing. "This device is able to detect what's going on in under five minutes." — Jack Hidary: Describing the magnetocardiography emergency-room triage application.
Implications: The conversation suggests quantum sensing and post-quantum security are near-term, real-world markets. For listeners, the takeaway is that the quantum era is not only about future computers but practical products now—navigation, medicine, drug discovery, and cybersecurity migration.